XNAS
INOD
Market cap2.00bUSD
Oct 08, Last price
61.20USD
1D
-3.49%
1Q
-9.73%
Jan 2017
2,397.96%
Name
Innodata Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Innodata Inc. is a global enterprise specializing in data engineering, with operations spanning the United States, the United Kingdom, the Netherlands, Canada, and other international locations. The firm conducts its business across three distinct divisions: Digital Data Solutions (DDS), Synodex, and Agility. Its Digital Data Solutions (DDS) division furnishes clients with AI-powered software platforms and outsourced services. These offerings cater to businesses needing data for the instruction of artificial intelligence (AI) and machine learning (ML) algorithms. DDS also delivers AI-driven digital transformation strategies, assisting organizations in leveraging AI/ML to extract critical insights from textual information. Furthermore, DDS provides a comprehensive suite of data engineering support functions, encompassing activities such as data annotation, transformation, curation, hygiene, consolidation, compliance, and master data management. The Synodex segment supplies an industry-specific platform designed to convert medical records into actionable digital data. This conversion utilizes either Synodex's proprietary data models or models provided by its clients. Lastly, the Agility division delivers a specialized platform for marketing and public relations experts. This platform enables them to identify and disseminate information to journalists and social media figures, alongside monitoring and dissecting content from global news outlets—including print, online, radio, and television—as well as various social media platforms. Innodata caters to a diverse clientele across sectors such as banking, insurance, financial services, technology, digital retail, and information/media. Its services are delivered by a dedicated team comprising professional staff, senior leadership, and direct sales representatives. The corporation, initially named Innodata Isogen, Inc., adopted its current moniker, Innodata Inc., in June 2012. Established in 1988, its principal office is situated in Ridgefield Park, New Jersey.
Related entities
Subsidiaries (2)
INNODATA DOCGENIX, LLC
INNODATA INDIA PRIVATE LIMITED
Key people
Jack Abuhoff
President, Chief Executive Officer, Director · since 2020
Marissa Espineli
Interim Chief Financial Officer · since 2022
Ashok Mishra
Chief Operating Officer, Executive Vice President · since 2007
Daniel Callahan
Independent Director · since 2025
Independent Director · since 2025
Louise Forlenza
Independent Director · since 2002
Stewart Massey
Lead Independent Director · since 2025
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
55 Challenger Road
Suite 202
Ridgefield Park, NJ 07660
US
Suite 202
Ridgefield Park, NJ 07660
US
Previous name
Innodata Isogen, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||